Reports for PHARMASCIENCE INC
Company Name
PHARMASCIENCE INC
Totals |
||
Shortage reports |
1235 |
|
| Actual shortage: | 52 (4%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 36 (3%) | |
| Resolved: | 1147 (93%) | |
Discontinuation Reports |
284 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 283 (100%) | |
| Reversed: | 1 (0%) | |
Late reports |
205 (13%) |
|
Overdue reports |
5 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CHARCODOTE SUSP 200MG/ML | 200MG | SUSPENSION | Resolved | 2017-04-07 | 2017-10-11 | 6019 |
| CHARCODOTE SUSP 200MG/ML | 200MG | SUSPENSION | Resolved | 2017-04-20 | 2020-06-09 | 7341 |
| ATORVASTATIN | 20MG | TABLET | Resolved | 2019-11-15 | 2020-07-23 | 98790 |
| ASAPHEN E.C. 80 MG | 80MG | TABLET (DELAYED-RELEASE) | Avoided shortage | 2018-03-07 | 2018-05-04 | 42092 |
| ASAPHEN E.C. 80 MG | 80MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-03-28 | 2019-05-09 | 79783 |
| ASAPHEN E.C. 80 MG | 80MG | TABLET (DELAYED-RELEASE) | Avoided shortage | 2017-05-02 | 2017-10-12 | 8528 |
| ASAPHEN E.C. 80 MG | 80MG | TABLET (DELAYED-RELEASE) | Avoided shortage | 2017-06-16 | 2017-10-12 | 13093 |
| ASAPHEN E.C. 80 MG | 80MG | TABLET (DELAYED-RELEASE) | Resolved | 2017-06-23 | 2018-05-05 | 13691 |
| ASAPHEN | 80MG | TABLET (CHEWABLE) | Resolved | 2017-04-20 | 2017-10-26 | 7328 |
| ASAPHEN | 80MG | TABLET (CHEWABLE) | Resolved | 2017-05-25 | 2017-09-19 | 11291 |
| ASAPHEN | 80MG | TABLET (CHEWABLE) | Resolved | 2019-11-15 | 2020-03-10 | 98787 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 8MG 15MG | TABLET | Resolved | 2017-03-24 | 2020-06-09 | 4161 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 8MG 15MG | TABLET | Resolved | 2017-06-23 | 2020-06-09 | 13688 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 8MG 15MG | TABLET | Resolved | 2017-12-07 | 2020-06-09 | 32028 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 8MG 15MG | TABLET | Resolved | 2018-03-23 | 2020-06-09 | 43848 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-TOPOTECAN | 4MG | POWDER FOR SOLUTION | Discontinued | 2017-04-07 | 2017-04-07 | 6081 |
| PMS-SUMATRIPTAN | 50MG | TABLET | Discontinued | 2021-11-16 | 2021-11-16 | 149391 |
| PMS-SULFASALAZINE-E.C. TAB 500MG | 500MG | TABLET (ENTERIC-COATED) | Discontinued | 2021-03-01 | 2021-03-01 | 134853 |
| PMS-SOLIFENACIN | 5MG | TABLET | Reversed | 2020-06-15 | 2020-10-06 | 117915 |
| PMS-SOLIFENACIN | 10MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117918 |
| PMS-SODIUM CROMOGLYCATE | 1% | SOLUTION | Discontinued | 2022-07-18 | 2023-04-12 | 164809 |
| PMS-SIMVASTATIN | 5MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117804 |
| PMS-SIMVASTATIN | 10MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117807 |
| PMS-SIMVASTATIN | 20MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117810 |
| PMS-SIMVASTATIN | 40MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117815 |
| PMS-SIMVASTATIN | 80MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117849 |
| PMS-SERTRALINE | 100MG | CAPSULE | Discontinued | 2021-03-11 | 2021-03-11 | 135481 |
| PMS-ROPINIROLE | 1.0MG | TABLET | Discontinued | 2018-06-06 | 2018-06-07 | 51699 |
| PMS-ROPINIROLE | 0.25MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117897 |
| PMS-ROPINIROLE | 2.0MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117900 |
| PMS-ROPINIROLE | 5.0MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117903 |
| PMS-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-06-17 | 2020-06-17 | 118150 |
| PMS-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-06-17 | 2020-06-17 | 118153 |
| PMS-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-06-17 | 2020-06-17 | 118156 |
| PMS-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-06-17 | 2020-06-17 | 118159 |